戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 posure prophylaxis, and sexual transmission (topical microbicide).
2 could serve as the basis of a broad-spectrum topical microbicide.
3 vent HIV-1 transmission in an antibody-based topical microbicide.
4 n bNAbs) could be novel candidates as potent topical microbicides.
5 12 studies), vaccination (7 studies), use of topical microbicides (10 studies), and prophylactic, cur
6 e unpredictability of antiviral compounds as topical microbicides and suggest that repeated exposures
7 ns can be applied to increase the potency of topical microbicides and vaccine-elicited antibodies.
8                                              Topical microbicides are a promising solution to address
9                                              Topical microbicides are an emerging HIV/AIDS prevention
10                                              Topical microbicides are being sought to prevent sexuall
11                           Safe and effective topical microbicides are biologically plausible.
12 ecreased by preexposure of EB to heat or the topical microbicide C31G, (iii) comparable among common
13  provides an intriguing prototype for future topical microbicide development.
14              Surrogate distribution suggests topical microbicides do not need to reach the uterus for
15       Despite potent in vitro efficacy, most topical microbicides fail to effectively prevent HIV tra
16  antiviral activities make CLR01 a promising topical microbicide for blocking infection by HIV and ot
17 n variants, such as PC-64a, could be used as topical microbicides for N. gonorrhoeae.
18 g the utility of the organ culture to screen topical microbicides for their ability to block sexual t
19                       The amount of UC781 in topical microbicide formulations under current developme
20                                              Topical microbicides offer an important alternative meth
21                                              Topical microbicide products are being developed for the
22 veloped to assess the safety and efficacy of topical microbicides proposed for use in humans.
23                                            A topical microbicide reduces the probability of virus tra
24                                              Topical microbicides represent a promising new approach
25 pical of biopsy data for tenofovir and other topical microbicides, results suggest downstream but hig
26                                              Topical microbicides that effectively block interactions
27                                        Thus, topical microbicides that interfere with HIV infection o
28                               Development of topical microbicides that prevent sexual transmission of
29  infectious form may aid HIV-1 in evasion of topical microbicides that target its intracellular produ
30 re LC, suggesting that it may be useful as a topical microbicide to block sexual transmission of HIV.
31 l therapies, and possibly as components of a topical microbicide to prevent HIV-1 sexual transmission
32              These types of molecules act as topical microbicides to prevent HIV infections in animal
33 lar umbrella compounds may function as novel topical microbicides to prevent human immunodeficiency v
34 nate polymer PRO 2000 are being developed as topical microbicides to protect against infection with s
35 ul for evaluating the safety and efficacy of topical microbicides when used rectally.